Home  »  Companies   »  Can Zomedica Corp. (ZOM) Remain Competitive?...

Can Zomedica Corp. (ZOM) Remain Competitive?

Zomedica Corp. (AMEX:ZOM) went down by -0.99% from its latest closing price compared to the recent 1-year high of $0.50. The company’s stock price has collected 11.64% of gains in the last five trading sessions.

Is It Worth Investing in Zomedica Corp. (AMEX :ZOM) Right Now?

Plus, the 36-month beta value for ZOM is at 0.82. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Zomedica Corp. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

The average price from analysts is $6.00, which is $5.72 above the current price. ZOM currently public float of 965.42M and currently shorts hold a 9.17% ratio of that float. Today, the average trading volume of ZOM was 9.60M shares.

ZOM’s Market Performance

ZOM stocks went up by 11.64% for the week, with a monthly jump of 66.97% and a quarterly performance of 32.86%, while its annual performance rate touched -16.96%. The volatility ratio for the week stands at 15.78% while the volatility levels for the past 30 days are set at 10.44% for Zomedica Corp. The simple moving average for the period of the last 20 days is 34.75% for ZOM stocks with a simple moving average of 15.93% for the last 200 days.

Analysts’ Opinion of ZOM

Many brokerage firms have already submitted their reports for ZOM stocks, with Dawson James repeating the rating for ZOM by listing it as a “Buy.” The predicted price for ZOM in the upcoming period, according to Dawson James is $6 based on the research report published on January 06th of the current year 2023.

ZOM Trading at 34.71% from the 50-Day Moving Average

After a stumble in the market that brought ZOM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.20% of loss for the given period.

Volatility was left at 10.44%, however, over the last 30 days, the volatility rate increased by 15.78%, as shares surge +67.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.41% upper at present.

During the last 5 trading sessions, ZOM rose by +11.64%, which changed the moving average for the period of 200-days by -17.87% in comparison to the 20-day moving average, which settled at $0.2127. In addition, Zomedica Corp. saw 71.17% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for ZOM

Current profitability levels for the company are sitting at:

  • -517.14 for the present operating margin
  • +46.32 for the gross margin

The net margin for Zomedica Corp. stands at -444.78. Equity return is now at value -6.50, with -6.30 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 46.18.